MF
DMAQR

Magnetar Financial’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

Magnetar Financial’s Portfolio DMAQR Stock Details DMAQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-242,900
Closed -$27 – 1660
2022
Q2 		$27 Sell
242,900
-47,900
-16% -$7.8K ﹤0.01% 1362
2022
Q1 		$52K Sell
290,800
-9,200
-3% -$2.33K ﹤0.01% 1245
2021
Q4 		$96K Buy
+300,000
New +$94.9K ﹤0.01% 1315

Other funds holding DMAQR

CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Magnetar Financial's DMAQR Position: Q3 2022 in Review

Magnetar Financial sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q3 2022, closing a stake of 242,900 shares — an estimated $27 sold.

Magnetar Financial first reported a position in DMAQR in Q4 2021 and held it in 3 quarters. The position peaked at $96K in Q4 2021. 30 funds tracked by Wall St. Rank hold DMAQR as of Q3 2022.

  • Magnetar Financial reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q3 2022 after selling out during the quarter.
  • Magnetar Financial sold 242,900 Deep Medicine Acquisition Corp. Rights shares in Q3 2022, an estimated $27.
  • Magnetar Financial first reported a position in Deep Medicine Acquisition Corp. Rights in Q4 2021 and held it in 3 quarters.
  • Magnetar Financial's Deep Medicine Acquisition Corp. Rights position peaked at $96K in Q4 2021.
  • 30 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q3 2022.

Based on Magnetar Financial's 13F filing for Q3 2022, filed 14 Nov 2022.